The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins

Research output: Contribution to conferenceOther

Original languageEnglish
PagesS.O.G.F.-S.O.G.F.
Publication statusPublished - 2007

Cite this